Home » Topics » BioWorld Science

BioWorld Science
RSS

University of Texas System patents CBP and KAT3B inhibitors

Oct. 29, 2019

Phase II results presented for TIMP-GLIA in celiac disease

Oct. 29, 2019

First known case of jaw keratocyst in an individual with SUFU-related Gorlin syndrome

Oct. 29, 2019

Autophagy defects caused by TRAPPC4 variant are associated with syndromic intellectual disability

Oct. 29, 2019

MyoKardia announces promising results from phase IIa study of MYK-491

Oct. 29, 2019

Microbion announces phase Ib data for pravibismane in infected diabetic foot ulcers

Oct. 29, 2019

Interim results presented from pivotal phase III SIERRA study of Iomab-B in AML

Oct. 29, 2019

First subject dosed in phase II ADVISE study of etrasimod in atopic dermatitis

Oct. 29, 2019

Heterozygous p.Leu47Val variant in HSPD1 causes hypomyelinating leukodystrophy

Oct. 29, 2019

BioCryst advances phase I study of BCX-9930 for paroxysmal nocturnal hemoglobinuria

Oct. 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...